Eden Research has completed a placing and retail offer
October 2023 — Eden Research plc has raised funds to build on its achievements in seed treatment, expand the markets for its existing biopesticide products, as well as invest in further developing its bioinsecticide.
Eden is the UK’s only AIM-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Our role in the transaction
Oaklins Cavendish, based in the UK, acted as nominated advisor in connection with Eden Research’s recent placing.
Talk to the deal team
Related deals
GVS has completed a voluntary partial tender offer for its own shares
GVS S.p.A. has completed a voluntary partial public tender offer for 12.3% of its own share capital.
Learn moreBalticovo has acquired Babičkin dvor
Balticovo has acquired 100% of the shares in Babičkin dvor. The acquisition marks Balticovo’s direct entry into the Slovak market and establishes a platform for further growth in Central Europe. Balticovo plans to expand Babičkin dvor’s production capacity through investments in new facilities, technology and know-how, supporting the continued development of domestic egg production in Slovakia.
Learn moreNutrition & Santé has divested its Spanish organic assets to Alimentos Sanygran
Nutrition & Santé Group has divested its Spanish organic assets to Alimentos Sanygran. The transaction included the Natursoy brand; the Castellterçol production site dedicated to organic chilled plant-based meat alternatives; a three-year Gerblé chilled-business license; manufacturing and transition services agreement (TSA) arrangements for Nutrition & Santé’s French Céréal Bio and Soy brands and third-party brands; distribution contracts for more than 10 organic brands; and a dedicated sales force serving specialized organic and dietetic retailers in Spain.
Learn more